Chronic therapy with the Acorn Cardiac Support Device (CSD) attenuates cardiomyocyte apoptosis in dogs with heart failure

被引：0
|
作者：
Gupta, RC [1 ]
Sharov, VG [1 ]
Mishra, S [1 ]
Todor, A [1 ]
Sabbah, HN [1 ]
机构：
[1] Henry Ford Hlth Syst, Detroit, MI USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2001年 / 37卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：478A / 478A
页数：1
相关论文
共 50 条
  • [41] Cardiomyocyte apoptosis and survival in hypertensive patients with chronic heart failure
    González, A
    López, B
    Querejeta, R
    Larman, M
    Fortuño, MA
    Díez, J
    AMERICAN JOURNAL OF HYPERTENSION, 2004, 17 (05) : 82A - 82A
  • [42] Passive cardiomyoplasty in congestive heart failure:: influence of the passive ACORN® Cardiac Support Device on left ventricular function
    Kleber, FX
    Sonntag, S
    Krebs, H
    Stantke, K
    Konertz, W
    EUROPEAN HEART JOURNAL, 2000, 21 : 533 - 533
  • [43] Prevention of progressive left ventricular dilation with the Acorn Cardiac Support Device downregulates stretch-response proteins and improves sarcoplasmic reticulum calcium cycling in dogs with chronic heart failure
    Sabbah, HN
    Gupta, RC
    Sharov, VG
    Todor, A
    Mishra, S
    Chaudhry, PA
    Suzuki, G
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (02) : 474A - 474A
  • [44] Device Therapy for chronic Heart Failure
    Toennis, T.
    HERZ, 2015, 40 (07) : 943 - 944
  • [45] Circulatory support in chronic heart failure by a physiological cardiac assist device that works synchronously with the heart
    Landesberg, A
    ter Keurs, HEDJ
    Shofti, R
    Shenhav, A
    Konyukhov, E
    Vaknin, Y
    Beyar, R
    CIRCULATION, 2003, 108 (17) : 560 - 560
  • [46] Prevention of progressive LV dilation with the acorn cardiac support device downregulates stretch response proteins and improves sarcoplasmic reticulum calcium cycling in dogs with heart failure
    Sabbah, HN
    Gupta, RC
    Sharov, VG
    Todor, A
    Mishra, S
    Chaudhry, PA
    Suzuki, G
    Morita, H
    EUROPEAN HEART JOURNAL, 2001, 22 : 95 - 95
  • [47] Inhibition of cardiomyocyte apoptosis prevents cardiac remodeling and transition to heart failure
    Paradis, P
    Dali-Youcef, N
    Wang, H
    Aries, A
    Mirotsou, M
    Pratt, R
    Nemer, M
    CIRCULATION, 2004, 110 (17) : 202 - 202
  • [48] Device-therapy in chronic heart failure: Cardiac contractility modulation versus cardiac resynchronization therapy
    Yuecel, Goekhan
    Gaasch, Leo
    Kodeih, Abbass
    Hetjens, Svetlana
    Yazdani, Babak
    Pfleger, Stefan
    Duerschmied, Daniel
    Abraham, William T.
    Akin, Ibrahim
    Kuschyk, Juergen
    ESC HEART FAILURE, 2025, 12 (01): : 456 - 466
  • [49] Intramyocardial administration of hepatocyte growth factor naked DNA plasmid attenuates cardiomyocyte apoptosis and normalizes apoptosis associated genes in dogs with heart failure
    Rastogi, S
    Imai, M
    Sharov, VG
    Todor, A
    Mishra, S
    Gupta, RC
    Khanal, S
    Goldstein, S
    Sabbah, HN
    CIRCULATION, 2005, 112 (17) : U358 - U358
  • [50] Nerol attenuates doxorubicin-induced heart failure by inhibiting cardiomyocyte apoptosis in rats
    He, Mei-ling
    Li, Xi-yue
    Guo, Ya-qi
    Li, Jiao
    Zhang, Jing
    Wang, Peng-yue
    Liu, Tong
    Yang, Jing
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2025, 987
12345